Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSohag University
About this trial
The aim of this study is to evaluate the clinicopathological pattern and surgical outcome of papillary thyroid carcinoma (PTC) at Sohag University Hospitals. This will help improve local risk stratification, optimize surgical decision-making, and guide future management strategies for patients with PTC in this region.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients diagnosed with papillary thyroid carcinoma and its variants managed at Sohag University Hospitals.
Confirmation of diagnosis histopathologically.
Availability of sufficient clinical, radiological, operative, and pathological data for analysis.
Disqualifiers
Patients diagnosed with other types of thyroid malignancy (e.g., follicular, medullary, or anaplastic carcinoma).
Patients with a history of previous thyroid surgery before presentation to the study setting.
Patients with incomplete essential medical records that prevent confirmation of diagnosis or extraction of main study variables.
Trial population
Patients diagnosed with papillary thyroid carcinoma (PTC) who are admitted and managed at the Department of General Surgery, Sohag University Hospitals, serving as a tertiary care center in Upper Egypt.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
30 Participants
are grouped into 1 trial groupGroup A: patients with papillary thyroid carcinoma
Trial outcomes
Primary outcomes
1
Prevalence of Extrathyroidal Extension in Papillary Thyroid Carcinoma
Percentage of participants with histologically confirmed extrathyroidal extension.
Time frame
9 monthsSecondary outcomes
1
Incidence of Early Postoperative Surgical Complications
Percentage of participants experiencing early postoperative complications including hypocalcemia, recurrent laryngeal nerve palsy, hematoma, seroma, or wound sepsis.
Time frame
9 months2
Incidence of Multifocal Papillary Thyroid Carcinoma
Percentage of participants found to have multifocal tumors on final histopathological examination.
Time frame
9 months3
Rate of Cervical Lymph Node Metastasis
Percentage of participants with histopathologically confirmed cervical lymph node metastasis.
Time frame
9 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: